BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9753209)

  • 1. Effect of troglitazone on urinary excretion of 6beta-hydroxycortisol.
    Koup JR; Anderson GD; Loi CM
    J Clin Pharmacol; 1998 Sep; 38(9):815-8. PubMed ID: 9753209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H; Echizen H; Nachi S; Ohnishi A
    Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers.
    Bauer S; Störmer E; Kerb R; Johne A; Brockmöller J; Roots I
    Eur J Clin Pharmacol; 2002 Dec; 58(9):581-5. PubMed ID: 12483450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes.
    Ramachandran V; Kostrubsky VE; Komoroski BJ; Zhang S; Dorko K; Esplen JE; Strom SC; Venkataramanan R
    Drug Metab Dispos; 1999 Oct; 27(10):1194-9. PubMed ID: 10497147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations.
    Kovacs SJ; Martin DE; Everitt DE; Patterson SD; Jorkasky DK
    Clin Pharmacol Ther; 1998 Jun; 63(6):617-22. PubMed ID: 9663175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I.
    Keung A; Reith K; Eller MG; McKenzie KA; Cheng L; Weir SJ
    Int J Tuberc Lung Dis; 1999 May; 3(5):426-36. PubMed ID: 10331733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEET (N,N-diethyl-m-toluamide) alone and in combination with permethrin increased urinary excretion of 6beta-hydroxycortisol in rats, a marker of hepatic CYP3A induction.
    Abu-Qare AW; Abou-Donia MB
    J Toxicol Environ Health A; 2001 Nov; 64(5):373-84. PubMed ID: 11700004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in urinary excretion of 6beta-hydroxycortisol in common marmosets as a marker of hepatic CYP3A induction.
    Totsuka S; Watanabe T; Koyanagi F; Tanaka K; Yasuda M; Manabe S
    Arch Toxicol; 1999; 73(4-5):203-7. PubMed ID: 10463384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE; Peng B; Hubert M; Krebs-Brown A; Capdeville R; Keller U; Seiberling M
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of amiodarone on urinary excretion of 6beta-hydroxycortisol in humans.
    Micuda S; Hodac M; Sispera L; Parízek P; Pleskot M; Zimova G; Cerman J; Martínková J; Pidrman V
    Physiol Res; 2001; 50(2):191-6. PubMed ID: 11522047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis.
    Dilger K; Denk A; Heeg MH; Beuers U
    Hepatology; 2005 Mar; 41(3):595-602. PubMed ID: 15726657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation of the urinary 6beta-hydroxycortisol to cortisol ratio that would reflect hepatic CYP3A activity.
    Ohno M; Yamaguchi I; Ito T; Saiki K; Yamamoto I; Azuma J
    Eur J Clin Pharmacol; 2000; 55(11-12):861-5. PubMed ID: 10805065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of troglitazone on cytochrome P450 enzymes in primary cultures of human and rat hepatocytes.
    Sahi J; Hamilton G; Sinz M; Barros S; Huang SM; Lesko LJ; LeCluyse EL
    Xenobiotica; 2000 Mar; 30(3):273-84. PubMed ID: 10752642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.
    Galteau MM; Shamsa F
    Eur J Clin Pharmacol; 2003 Dec; 59(10):713-33. PubMed ID: 14605790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats.
    Li J; Kaneko T; Wang Y; Qin LQ; Wang PY; Sato A
    Toxicology; 2002 Jul; 176(1-2):91-100. PubMed ID: 12062933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of urinary free cortisol and 6beta-hydroxycortisol by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry and its application for estimating hepatic CYP3A induction.
    Tang C; Kassahun K; McIntosh IS; Brunner J; Rodrigues AD
    J Chromatogr B Biomed Sci Appl; 2000 Jun; 742(2):303-13. PubMed ID: 10901135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vivo effects of sho-saiko-to, a traditional Chinese herbal medicine, on two cytochrome P450 enzymes (1A2 and 3A) and xanthine oxidase in man.
    Saruwatari J; Nakagawa K; Shindo J; Nachi S; Echizen H; Ishizaki T
    J Pharm Pharmacol; 2003 Nov; 55(11):1553-9. PubMed ID: 14713367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midazolam and cortisol metabolism before and after CYP3A induction in humans.
    Eeckhoudt SL; Desager JP; Robert AR; Leclercq I; Verbeeck RK; Horsmans Y
    Int J Clin Pharmacol Ther; 2001 Jul; 39(7):293-9. PubMed ID: 11471773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans.
    Furuta T; Suzuki A; Mori C; Shibasaki H; Yokokawa A; Kasuya Y
    Drug Metab Dispos; 2003 Nov; 31(11):1283-7. PubMed ID: 14570755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of urinary 6beta-hydroxycortisol/cortisol ratio between neonates and their mothers.
    Nakamura H; Hasegawa A; Kimura M; Yamagata S; Nakasa H; Osada H; Sekiya S; Ohmori S; Kitada M
    Br J Clin Pharmacol; 1999 Jan; 47(1):31-4. PubMed ID: 10073736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.